Shandong Linuo Pharmaceutical Packaging Co., Ltd. (SHE:301188)
China · Delayed Price · Currency is CNY 17.24
-0.59 (-3.31%)
At close: Feb 13, 2026
SHE:301188 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 945.25 | 1,055 | 924.39 | 767.42 | 881.32 | 645.3 |
Other Revenue | 25.73 | 25.73 | 22.97 | 54.6 | 7.56 | 14.76 |
| 970.98 | 1,081 | 947.37 | 822.02 | 888.88 | 660.05 | |
Revenue Growth (YoY) | -10.67% | 14.09% | 15.25% | -7.52% | 34.67% | 0.58% |
Cost of Revenue | 785.83 | 884.89 | 787.73 | 646.56 | 670.42 | 494.03 |
Gross Profit | 185.15 | 195.95 | 159.64 | 175.47 | 218.46 | 166.02 |
Selling, General & Admin | 101.1 | 87.03 | 67.7 | 49.69 | 49.81 | 42.62 |
Research & Development | 35 | 33.8 | 30.13 | 25.96 | 32.5 | 24.26 |
Other Operating Expenses | 4.33 | 2.59 | 2.61 | 5.79 | 6.29 | 4.85 |
Operating Expenses | 140.84 | 124.73 | 102.68 | 81.48 | 90.95 | 72.02 |
Operating Income | 44.31 | 71.22 | 56.96 | 93.99 | 127.51 | 94 |
Interest Expense | -27.49 | -25.81 | -9.04 | - | -0.99 | -2.37 |
Interest & Investment Income | 11.92 | 18.59 | 16.27 | 15.04 | 6.21 | 4.88 |
Currency Exchange Gain (Loss) | 2.04 | 2.04 | -0.02 | 5.62 | -2.2 | -1.81 |
Other Non Operating Income (Expenses) | -0.49 | -0.56 | -0.85 | 0.44 | -0.07 | -0.28 |
EBT Excluding Unusual Items | 30.29 | 65.49 | 63.33 | 115.08 | 130.45 | 94.42 |
Gain (Loss) on Sale of Investments | 2.16 | 1.45 | 2.15 | 1.35 | - | - |
Gain (Loss) on Sale of Assets | 2.4 | 0.03 | 0.05 | 0.47 | 0.45 | 0.54 |
Asset Writedown | -1.43 | -0.65 | -0.05 | -0.01 | -0.07 | -0.02 |
Legal Settlements | - | - | - | - | - | -0.1 |
Other Unusual Items | 17.22 | 5.13 | 7.33 | 9.83 | 9.45 | 7.3 |
Pretax Income | 50.63 | 71.45 | 72.81 | 126.72 | 140.27 | 102.15 |
Income Tax Expense | 4.15 | 5.38 | 6.89 | 10.07 | 15.49 | 11.35 |
Net Income | 46.48 | 66.07 | 65.92 | 116.65 | 124.78 | 90.8 |
Net Income to Common | 46.48 | 66.07 | 65.92 | 116.65 | 124.78 | 90.8 |
Net Income Growth | -43.83% | 0.23% | -43.49% | -6.51% | 37.42% | 9.58% |
Shares Outstanding (Basic) | 225 | 228 | 235 | 233 | 178 | 175 |
Shares Outstanding (Diluted) | 225 | 228 | 235 | 233 | 178 | 175 |
Shares Change (YoY) | -4.89% | -3.23% | 0.91% | 30.88% | 2.08% | 1.15% |
EPS (Basic) | 0.21 | 0.29 | 0.28 | 0.50 | 0.70 | 0.52 |
EPS (Diluted) | 0.21 | 0.29 | 0.28 | 0.50 | 0.70 | 0.52 |
EPS Growth | -40.94% | 3.57% | -44.00% | -28.57% | 34.62% | 8.33% |
Free Cash Flow | -261.32 | -86.55 | -52.04 | -115.99 | -20.91 | 13.47 |
Free Cash Flow Per Share | -1.16 | -0.38 | -0.22 | -0.50 | -0.12 | 0.08 |
Dividend Per Share | 0.100 | 0.100 | 0.100 | 0.200 | 0.200 | - |
Dividend Growth | - | - | -50.00% | - | - | - |
Gross Margin | 19.07% | 18.13% | 16.85% | 21.35% | 24.58% | 25.15% |
Operating Margin | 4.56% | 6.59% | 6.01% | 11.43% | 14.34% | 14.24% |
Profit Margin | 4.79% | 6.11% | 6.96% | 14.19% | 14.04% | 13.76% |
Free Cash Flow Margin | -26.91% | -8.01% | -5.49% | -14.11% | -2.35% | 2.04% |
EBITDA | 166.81 | 176.62 | 139.55 | 159.27 | 182.64 | 141.46 |
EBITDA Margin | 17.18% | 16.34% | 14.73% | 19.38% | 20.55% | 21.43% |
D&A For EBITDA | 122.51 | 105.4 | 82.59 | 65.28 | 55.14 | 47.46 |
EBIT | 44.31 | 71.22 | 56.96 | 93.99 | 127.51 | 94 |
EBIT Margin | 4.56% | 6.59% | 6.01% | 11.43% | 14.34% | 14.24% |
Effective Tax Rate | 8.20% | 7.53% | 9.46% | 7.94% | 11.04% | 11.11% |
Revenue as Reported | 970.98 | 1,081 | 947.37 | 822.02 | 888.88 | 660.05 |
Advertising Expenses | - | 4.42 | 2.72 | 0.33 | 0.58 | 1.06 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.